Forma Therapeutics Holdings, Inc. Common Stock
FMTX
FMTX was delisted on the 13th of October, 2022.
59 hedge funds and large institutions have $1.38B invested in Forma Therapeutics Holdings, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
500% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 7
146% more funds holding
Funds holding: 24 → 59 (+35)
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
17% more capital invested
Capital invested by funds: $1.17B → $1.38B (+$204M)
2.36% more ownership
Funds ownership: 65.01% → 67.37% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$36.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.5M |
| 3 |
Janus Henderson Group
London,
|
+$19.7M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$9.8M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$14.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.4M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$11M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$9.23M |
| 5 |
Goldman Sachs
New York
|
-$4.49M |
FMTX Hedge Fund Activity: Q3 2020 in Review
59 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q3 2020, worth a combined $1.38B — up 17% from $1.17B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new FMTX positions and 7 closed out — a net gain of 35 holders — while 7 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $36.3M. The largest seller was Millennium Management, exiting entirely with an estimated $14.6M sold.
- 59 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q3 2020, up from 24 in Q2 2020.
- Funds reported $1.38B of Forma Therapeutics Holdings, Inc. Common Stock stock for Q3 2020, up 17% quarter-over-quarter.
- 42 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q3 2020 and 7 closed out, a net change of +35 holders.
- The largest Forma Therapeutics Holdings, Inc. Common Stock buyer in Q3 2020 was BlackRock, an estimated $36.3M added.
- The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q3 2020 was Millennium Management, an estimated $14.6M sold.
Based on aggregated 13F filings for Q3 2020.